Kerrii B.  Anderson net worth and biography

Kerrii Anderson Biography and Net Worth

Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Ms. Anderson is the former Chief Executive Officer, President and Chief Financial Officer of Wendy’s International. Prior to joining Wendy’s in 2000, she was senior vice president and chief financial officer for 14 years for M/I Schottenstein Homes, Inc., a NYSE company that builds single-family homes.

Ms. Anderson has served as a director of Abercrombie & Fitch Co. since February 2018, The Sherwin-Williams Company since April 2019, and Worthington Industries, Inc. since September 2010. She was previously a director of the board of Chiquita Brands International from 2009 to 2012, and was chairwoman of the board from 2012 until the company’s acquisition in 2015. She was also a member of the board of P.F. Chang’s China Bistro from 2009 to 2012. Ms. Anderson also serves on the boards of the following non-profit entities: The Columbus Foundation, Ohio Health Board of Trustees and Elon University Board of Trustees.

Ms. Anderson has a strong record of leadership in operations, strategy, finance and talent management as a result of her experience at Wendy’s. Ms. Anderson also has significant expertise in the areas of accounting and financial reporting, corporate finance, corporate governance, and executive compensation through her service on other large public company boards. The breadth of experience enables Ms. Anderson to advise our Board on a variety of matters related to global operations and business strategy.

What is Kerrii B. Anderson's net worth?

The estimated net worth of Kerrii B. Anderson is at least $3.32 million as of May 2nd, 2024. Ms. Anderson owns 15,722 shares of Laboratory Co. of America stock worth more than $3,323,159 as of July 21st. This net worth approximation does not reflect any other investments that Ms. Anderson may own. Learn More about Kerrii B. Anderson's net worth.

How do I contact Kerrii B. Anderson?

The corporate mailing address for Ms. Anderson and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Kerrii B. Anderson's contact information.

Has Kerrii B. Anderson been buying or selling shares of Laboratory Co. of America?

Kerrii B. Anderson has not been actively trading shares of Laboratory Co. of America in the last ninety days. Most recently, Kerrii B. Anderson sold 250 shares of the business's stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $200.10, for a transaction totalling $50,025.00. Following the completion of the sale, the director now directly owns 15,722 shares of the company's stock, valued at $3,145,972.20. Learn More on Kerrii B. Anderson's trading history.

Who are Laboratory Co. of America's active insiders?

Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.

Are insiders buying or selling shares of Laboratory Co. of America?

During the last year, insiders at the medical research company sold shares 15 times. They sold a total of 65,628 shares worth more than $14,131,610.38. The most recent insider tranaction occured on May, 14th when EVP Der Vaart Sandra D Van sold 2,000 shares worth more than $421,660.00. Insiders at Laboratory Co. of America own 0.9% of the company. Learn More about insider trades at Laboratory Co. of America.

Information on this page was last updated on 5/14/2024.

Kerrii B. Anderson Insider Trading History at Laboratory Co. of America

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/2/2024Sell250$200.10$50,025.0015,722View SEC Filing Icon  
4/30/2024Sell250$204.13$51,032.5015,972View SEC Filing Icon  
8/8/2023Sell5,000$211.57$1,057,850.0015,275View SEC Filing Icon  
9/23/2019Sell2,600$171.85$446,810.00View SEC Filing Icon  
6/20/2019Sell3,100$170.00$527,000.0022,233View SEC Filing Icon  
11/5/2018Sell3,700$163.29$604,173.0021,795View SEC Filing Icon  
See Full Table

Kerrii B. Anderson Buying and Selling Activity at Laboratory Co. of America

This chart shows Kerrii B Anderson's buying and selling at Laboratory Co. of America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Laboratory Co. of America Company Overview

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $211.37
Low: $210.27
High: $216.32

50 Day Range

MA: $203.40
Low: $192.50
High: $216.50

2 Week Range

Now: $211.37
Low: $191.97
High: $234.09

Volume

585,940 shs

Average Volume

514,880 shs

Market Capitalization

$17.82 billion

P/E Ratio

42.53

Dividend Yield

1.36%

Beta

1.05